We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Bladder Cancer

Journal Scan / Commentary · May 24, 2022

Gene Signature for the Prediction of Recurrence and Progression of NMIBC

Molecular Biomedicine


Additional Info

Molecular Biomedicine
Identification of a gene signature for the prediction of recurrence and progression in non-muscle-invasive bladder cancer
Mol Biomed 2022 Mar 15;3(1)9, E Dalla, R Picco, G Novara, FD Moro, C Brancolini

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading